GAA
GRTX

Global Assets Advisory’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Global Assets Advisory’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-24,500
Closed -$72.7K – 143
2023
Q2 		$72.7K Buy
+24,500
New +$72.9K 0.07% 116

Other funds holding GRTX

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Global Assets Advisory's GRTX Position: Q3 2023 in Review

Global Assets Advisory sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q3 2023, closing a stake of 24,500 shares — an estimated $72.7K sold.

Global Assets Advisory first reported a position in GRTX in Q2 2023 and held it in 1 quarter. The position peaked at $72.7K in Q2 2023. 38 funds tracked by Wall St. Rank hold GRTX as of Q3 2023.

  • Global Assets Advisory reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Global Assets Advisory sold 24,500 Galera Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $72.7K.
  • Global Assets Advisory first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Global Assets Advisory's Galera Therapeutics, Inc. Common Stock position peaked at $72.7K in Q2 2023.
  • 38 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Global Assets Advisory's 13F filing for Q3 2023, filed 4 Oct 2023.